Abundance and Density of Mountain Plover (\u3ci\u3eCharadrius montanus\u3c/i\u3e) and Burrowing Owl (\u3ci\u3eAthene cunicularia\u3c/i\u3e) in Eastern Colorado

Because of continental-scale declines of grassland birds over the past century, conservation agendas are focused on increasing understanding of grassland bird ecology and habitat associations. Shortgrass prairie is a unique grassland ecosystem maintained, in part, by Black-tailed Prairie Dogs (Cynomys ludovicianus). The Mountain Plover (Charadrius montanus) and western Burrowing Owl (Athene cunicularia hypugaea) are species of conservation concern known to be associated with prairie dog colonies. We estimated abundance of Mountain Plovers and Burrowing Owls in three habitats within the Colorado shortgrass prairie ecosystem— prairie dog colonies, grassland not occupied by prairie dogs, and dryland agriculture. Further, we investigated habitat associations of Mountain Plovers and Burrowing Owls at multiple landscape scales. We estimated 8,577 Mountain Plovers (95% CI: 7,511–35,130) and 3,554 Burrowing Owls (95% CI: 3,298–8,445) in eastern Colorado. Mountain Plover density on prairie dog colony plots (ˆD = 2.26 birds per 100 ha, 95% CI: 2.15–5.13) was significantly higher than densities on either grassland (ˆD = 0.23, 95% CI: 0.17–1.76) or dryland- agriculture plots (ˆD = 0.45, 95% CI: 0.44–0.53). Burrowing Owl density on prairie dog colony plots (ˆD = 3.04 birds per 100 ha, 95% CI: 2.82–6.92) was significantly higher than densities on either grassland (ˆD = 0.044, 95% CI: 0.041–0.12) or dryland-agriculture plots (no Burrowing Owls detected). Our results suggest that increased prairie dog colonies would positively influence the abundance of Mountain Plover and Burrowing Owl

Use of Monofilament Line, Reflective Tape, Beach-Balls, and Pyrotechnics for Controlling Grackle Damage to Citrus

The effectiveness of monofilament line, reflective tape, beach-balls and pyrotechnics (propane cannons and shotgun scare shells) in reducing damage to citrus by great-tailed grackles was tested in the lower Rio Grande Valley of southern Texas. Results indicate that these treatments can produce reduction in damage. Whether the treatments are economically advisable for a grower depends on the history of grackle damage to the grove and grove size. Only large amounts of damage in large groves justify costs associated with implementation of these methods

Use of Monofilament Line, Reflective Tape, Beach-Balls, and Pyrotechnics for Controlling Grackle Damage to Citrus

The effectiveness of monofilament line, reflective tape, beach-balls and pyrotechnics (propane cannons and shotgun scare shells) in reducing damage to citrus by great-tailed grackles was tested in the lower Rio Grande Valley of southern Texas. Results indicate that these treatments can produce reduction in damage. Whether the treatments are economically advisable for a grower depends on the history of grackle damage to the grove and grove size. Only large amounts of damage in large groves justify costs associated with implementation of these methods

Radioprotectant Activity of 5-Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice

Survival and changes in mean body mass of whole-body irradiated mice were determined to examine the radioprotectant activity of 5-diethylsulfonamoylsalicylatocopper(II) [Cu(II) (5-DESS)]. One of four groups of 25 female C57BL/6 mice were treated subcutaneously (sc)with 0, 10, 20, 40, 60, 80, 100, or 120 μmol Cu(II)(5- DESS)/kg of body mass 3 hours before exposure to 8.0 Gy, gamma irradiation. In this paradigm, doses of Cu(II)(5- DESS) increased survival up to 92% above vehicle-treated control mice (P = 0.008). Mean body mass determinations revealed that mice treated with 80 to 120 μmol Cu(II)(5-DESS)/kg of body mass exhibited a smaller decrease in body mass than other complex-treated groups. These results support the hypothesis that Cu(II)(5-DESS) is an effective radioprotectant

Changes in body composition and performance with supplemental HMB-FA+ATP (Manuscript Clarification)

Additional co-authors: Matthew D. Vukovich, Colin Wilborn, and Darryn S. Willoughb

Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

Background &amp; Aims: Comparative assessments of immunogenicity following different COVID-19 vaccines in patients with distinct liver diseases are lacking. SARS-CoV-2-specific T-cell and antibody responses were evaluated longitudinally after one to three vaccine doses, with long-term follow-up for COVID-19-related clinical outcomes. Methods: A total of 849 participants (355 with cirrhosis, 74 with autoimmune hepatitis [AIH], 36 with vascular liver disease [VLD], 257 liver transplant recipients [LTRs] and 127 healthy controls [HCs]) were recruited from four countries. Standardised immune assays were performed pre and post three vaccine doses (V1-3). Results: In the total cohort, there were incremental increases in antibody titres after each vaccine dose (p &lt;0.0001). Factors associated with reduced antibody responses were age and LT, whereas heterologous vaccination, prior COVID-19 and mRNA platforms were associated with greater responses. Although antibody titres decreased between post-V2 and pre-V3 (p = 0.012), patients with AIH, VLD, and cirrhosis had equivalent antibody responses to HCs post-V3. LTRs had lower and more heterogenous antibody titres than other groups, including post-V3 where 9% had no detectable antibodies; this was heavily influenced by intensity of immunosuppression. Vaccination increased T-cell IFNγ responses in all groups except LTRs. Patients with liver disease had lower functional antibody responses against nine Omicron subvariants and reduced T-cell responses to Omicron BA.1-specific peptides compared to wild-type. 122 cases of breakthrough COVID-19 were reported of which 5/122 (4%) were severe. Of the severe cases, 4/5 (80%) occurred in LTRs and 2/5 (40%) had no serological response post-V2. Conclusion: After three COVID-19 vaccines, patients with liver disease generally develop robust antibody and T-cell responses to vaccination and have mild COVID-19. However, LTRs have sustained no/low antibody titres and appear most vulnerable to severe disease. Impact and implications: Standardised assessments of the immune response to different COVID-19 vaccines in patients with liver disease are lacking. We performed antibody and T-cell assays at multiple timepoints following up to three vaccine doses in a large cohort of patients with a range of liver conditions. Overall, the three most widely available vaccine platforms were immunogenic and appeared to protect against severe breakthrough COVID-19. This will provide reassurance to patients with chronic liver disease who were deemed at high risk of severe COVID-19 during the pre-vaccination era, however, liver transplant recipients had the lowest antibody titres and remained vulnerable to severe breakthrough infection. We also characterise the immune response to multiple SARS-CoV-2 variants and describe the interaction between disease type, severity, and vaccine platform. These insights may prove useful in the event of future viral infections which also require rapid vaccine development and delivery to patients with liver disease.</p

Human skeletal muscle is refractory to the anabolic effects of leucine during the postprandial muscle-full period in older men

Leucine modulates muscle protein synthesis (MPS), with potential to facilitate accrual/maintenance of muscle mass. Animal models suggest that leucine boluses shortly after meals may prolong MPS and delay onset of a “muscle-full” state. However, the effects of nutrient “top-ups” in humans, and particularly older adults where deficits exist, have not been explored. We determined the effects of a leucine top-up after essential amino acid (EAA) feeding on anabolic signaling, MPS, and muscle energy metabolism in older men. During 13C6-phenylalanine infusion, 16 men (∼70 years) consumed 15 g of EAA with (n=8, FED + LEU) or without (n=8, FED) 3 g of leucine top-up 90 min later. Repeated blood and muscle sampling permitted measurement of fasting and postprandial plasma EAA, insulin, anabolic signaling including mTOR complex 1 (mTORC1) substrates, cellular ATP and phosphorylocreatine, and MPS. Oral EAA achieved rapid insulinemia (12.5 iU·ml−1 25 min post-feed), essential aminoacidemia (3000 μM, 45–65 min post-feed), and activation of mTORC1 signaling. Leucine top-up prolonged plasma EAA (2800 μM, 135 min) and leucine availability (1050 μM, 135 min post-feed). Fasting FSRs of 0.046 and 0.056%·h-1 (FED and FED + LEU respectively) increased to 0.085 and 0.085%·h-1 90–180 min post-feed and returned to basal rates after 180 min in both groups. Phosphorylation of mTORC1 substrates returned to fasting levels 240 min post-feed in both groups. Feeding had limited effect on muscle elongation factor 2 (eEF2) phosphorylation. We demonstrate the refractoriness of muscle to nutrient-led anabolic stimulation in the postprandial period; thus, leucine supplements should be taken outside of meals, or with meals containing suboptimal protein in terms of either amount or EAA composition